CD28 AND CTLA-4 HAVE OPPOSING EFFECTS ON THE RESPONSE OF T-CELLS TO STIMULATION

被引:1715
|
作者
KRUMMEL, MF
ALLISON, JP
机构
[1] UNIV CALIF BERKELEY, DEPT MOLEC & CELL BIOL, BERKELEY, CA 94720 USA
[2] UNIV CALIF BERKELEY, CANC RES LAB, BERKELEY, CA 94720 USA
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 1995年 / 182卷 / 02期
关键词
D O I
10.1084/jem.182.2.459
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The importance of the B7/CD28/CTLA-4 molecules has been established in studies of antigen-presenting cell-derived B7 and its interaction with the T cell costimulatory molecule CD28. CTLA-4, a T cell surface glycoprotein that is related to CD28, can also interact with B7-1 and B7-2. However, less is known about the function of CTLA-4, which is expressed at highest levels after activation. We have generated an antibody to CTLA-4 to investigate the consequences of engagement of this molecule in a carefully defined system using highly purified T cells. We show here that the presence of low levels of B7-2 on freshly explanted T cells can partially inhibit T cell proliferation, and this inhibition is mediated by interactions with CTLA-4. Cross-linking of CTLA-4 together with the TCR and CD28 strongly inhibits proliferation and IL-2 secretion by T cells. Finally, results show that CD28 and CTLA-4 deliver opposing signals that appear to be integrated by the T cell in determining the response to activation. These data strongly suggest that the outcome of T cell antigen receptor stimulation is regulated by CD28 costimulatory signals, as well as inhibitory signals derived from CTLA-4.
引用
收藏
页码:459 / 465
页数:7
相关论文
共 50 条
  • [41] Challenges and opportunities in targeting the CD28/CTLA-4 pathway in transplantation and autoimmunity
    Crepeau, Rebecca L.
    Ford, Mandy L.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (08) : 1001 - 1012
  • [42] CD28/CTLA-4及其配体的研究进展
    刘慧萍
    张远强
    李恩善
    解剖科学进展, 1997, (01) : 62 - 66
  • [43] Association of CD28 and CTLA-4 gene polymorphisms with aggressive periodontitis in Brazilians
    Silva, M. R. M. A. e
    Moreira, P. R.
    da Costa, G. C.
    Saraiva, A. M.
    de Souza, P. E. A.
    Amormino, S. A. F.
    da Costa, J. E.
    Gollob, K. J.
    Dutra, W. O.
    ORAL DISEASES, 2013, 19 (06) : 568 - 576
  • [44] Stimulation of CD4+ T cells to secrete the inhibitor soluble CTLA-4
    Ward, FJ
    Wassall, H
    Rowe, C
    Vickers, MA
    Barker, RN
    IMMUNOLOGY, 2005, 116 : 12 - 12
  • [45] 白癜风患者外周血T淋巴细胞CD28、CTLA-4的表达
    杜军波
    于建斌
    黄建敏
    张江安
    苗青
    张斌
    张毅
    郑州大学学报(医学版), 2012, 47 (06) : 776 - 778
  • [46] TCR Signaling and CD28/CTLA-4 Signaling Cooperatively Modulate T Regulatory Cell Homeostasis
    Holt, Michael P.
    Punkosdy, George A.
    Glass, Deborah D.
    Shevach, Ethan M.
    JOURNAL OF IMMUNOLOGY, 2017, 198 (04): : 1503 - 1511
  • [47] Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy
    Wells, AD
    Walsh, MC
    Bluestone, JA
    Turka, LA
    JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (06): : 895 - 903
  • [48] SELECTIVE CD28 BLOCKADE SYNERGIZES WITH REGULATORY T CELL ACTIVITY IN A CTLA-4 DEPENDENT MANNER
    Dilek, Nahzli
    Poirier, Nicolas
    Hulin, Philippe
    Vanhove, Bernard
    Blancho, Gilles
    TRANSPLANT INTERNATIONAL, 2009, 22 : 30 - 31
  • [49] Tolerogenic dendritic cells suppress murine corneal allograft rejection by modulating CD28/CTLA-4 expression on regulatory T cells
    Yan, Feng
    Cai, Li
    Hui, Yannian
    Chen, Suihua
    Meng, Hao
    Huang, Zhenping
    CELL BIOLOGY INTERNATIONAL, 2014, 38 (07) : 835 - 848
  • [50] A NOVEL FULLY HUMAN CD28 ANTIBODY THAT CROSSREACTS WITH CTLA-4 AND MOUSE CD28 FOR POTENTIAL APPLICATIONS IN CANCER IMMUNOTHERAPY
    Elsayed, Abdullah
    Peissert, Frederik
    Pluss, Louis
    Ulrich, Franziska
    Puca, Emanuele
    De Luca, Roberto
    Halin, Cornelia
    Neri, Dario
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1116 - A1116